Case Reports

Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication
Wei Wang, Meihong Wu, Minglu Liu, Zhengqing Yan, Guoqiang Wang, Dongliang Mao, Mei Wang

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000793; DOI: 10.1136/jitc-2020-000793
Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
Kartik Sehgal, Andreas Varkaris, Hollis Viray, Paul A VanderLaan, Deepa Rangachari, Daniel B Costa

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000697; DOI: 10.1136/jitc-2020-000697
Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy
William Murray-Brown, Tom D Wilsdon, Helen Weedon, Susanna Proudman, Shawgi Sukumaran, Sonja Klebe, Jennifer G Walker, Malcolm D Smith, Mihir D Wechalekar

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000281; DOI: 10.1136/jitc-2019-000281
Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients
Megan H Trager, Shana M Coley, Geoffrey Dube, Shaheer Khan, Matthew Ingham, Faramarz H Samie, Larisa J Geskin, Diana McDonnell, Daniel Brouder, Yvonne Saenger, Richard Carvajal

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000908; DOI: 10.1136/jitc-2020-000908
Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report
Yongyi Zeng, Wei Zhang, Zhenli Li, Youshi Zheng, Yingchao Wang, Geng Chen, Liman Qiu, Kun Ke, Xiaoping Su, Zhixiong Cai, Jingfeng Liu, Xiaolong Liu

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000217; DOI: 10.1136/jitc-2019-000217
Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy
Michael T Serzan, Princy N Kumar, Michael B Atkins

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000898; DOI: 10.1136/jitc-2020-000898
Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma
Karoline Ehlert, Ina Hansjuergens, Andreas Zinke, Sylke Otto, Nikolai Siebert, Guenter Henze, Holger Lode

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000540; DOI: 10.1136/jitc-2020-000540
CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome
Liting Chen, Bin Xu, Xiaolu Long, Jia Gu, Yaoyao Lou, Di Wang, Yang Cao, Na Wang, Chunrui Li, Gaoxiang Wang, Ying Wang, Li Zhu, Jin Wang, Haiyun An, Min Xiao, Yi Xiao, Jianfeng Zhou

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000364; DOI: 10.1136/jitc-2019-000364
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, Shihong Zhang, Karan Kohli, Jianhong Cao, Jose G Mantilla, Ernest U Conrad, Stanley R Riddell, Robin L Jones, Cassian Yee, Seth M Pollack

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000247; DOI: 10.1136/jitc-2019-000247
Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability
Yuanquan Yang, Rohit K Jain, Sean T Glenn, Bo Xu, Prashant K Singh, Lei Wei, Qiang Hu, Mark Long, Nicholas Hutson, Jianming Wang, Sebastiano Battaglia, Saby George

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000128; DOI: 10.1136/jitc-2019-000128

Main menu

Case Reports

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Case Reports

Pages